WallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for JNJ

Based on 4 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$178.00+8.96%
Avg Forecast
$189.50+16%
Max Forecast
$200.00+22.43%

Should I buy or sell JNJ stock?

Based on 4 analysts offering ratings for Johnson & Johnson.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 75%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

JNJ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Top 13%
88
BuyMaintains$178.00+8.96%2021-10-20
Morgan Stanley
Top 30%
71
HoldDowngrades$187.00+14.47%2021-09-07
Credit Suisse
Top 23%
78
BuyMaintains$193.00+18.14%2021-01-27
Anonymous
Morgan Stanley
Strong BuyMaintains$187.00+14.47%2021-01-27
SVB Leerink
Bottom 4%
4
BuyMaintains$200.00+22.43%2021-01-27

1 of 1

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
43.94%
Industry
67.27%
Market
37.02%
JNJ's Return on Equity is forecast to be high in 3 years (43.94%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
17.23%
Industry
15.85%
JNJ is forecast to generate higher Return on Assets (17.23%) than the US Drug Manufacturers - General industry average (15.85%)
Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$9.65+42.33%
Avg 2 year Forecast
$10.30+51.92%
Avg 3 year Forecast
$11.14+64.31%
JNJ's earnings are forecast to grow at a rate of 17.75% per year, which is not exceptional
Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$94.2B+3.04%
Avg 2 year Forecast
$98.4B+7.66%
Avg 3 year Forecast
$102.1B+11.66%
JNJ's revenue is forecast to grow at a rate of 3.78% per year, which is not exceptional
Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.75%
Industry
23.23%
Market
14.37%
JNJ's earnings are forecast to grow slower (17.75% per year) than the US Drug Manufacturers - General industry average (23.23%)
Forecast
JNJ's earnings are forecast to grow faster (17.75% per year) than the US market average (14.37%)
Forecast
JNJ's earnings are forecast to grow faster (17.75% per year) than the risk-free savings rate (1.5%)
Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.78%
Industry
4.01%
Market
10.03%
JNJ's revenues are forecast to grow slower (3.78% per year) than the US Drug Manufacturers - General industry average (4.01%)
Forecast
JNJ's revenues are forecast to grow slower (3.78% per year) than the US market average (10.03%)
Forecast

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: JNJ) stock is to Buy JNJ stock.

Out of 4 analysts, 0 (0%) are recommending JNJ as a Strong Buy, 3 (75%) are recommending JNJ as a Buy, 1 (25%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

What is JNJ's earnings growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 17.75% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 23.23%, and while it is forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Johnson & Johnson's earnings in 2021 is $17,880,000,000.On average, 9 Wall Street analysts forecast JNJ's earnings for 2021 to be $25,404,560,751, with the lowest JNJ earnings forecast at $25,272,930,902, and the highest JNJ earnings forecast at $25,483,538,660. On average, 9 Wall Street analysts forecast JNJ's earnings for 2022 to be $27,115,748,781, with the lowest JNJ earnings forecast at $25,220,278,963, and the highest JNJ earnings forecast at $27,773,898,023.

In 2023, JNJ is forecast to generate $29,327,130,235 in earnings, with the lowest earnings forecast at $28,774,284,871 and the highest earnings forecast at $29,748,345,750.

What is JNJ's revenue growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 3.78% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.03%.

Johnson & Johnson's revenue in 2021 is $91,446,000,000.On average, 5 Wall Street analysts forecast JNJ's revenue for 2021 to be $248,062,314,830,072, with the lowest JNJ revenue forecast at $247,714,922,599,237, and the highest JNJ revenue forecast at $248,390,789,219,088. On average, 5 Wall Street analysts forecast JNJ's revenue for 2022 to be $259,171,363,315,440, with the lowest JNJ revenue forecast at $256,414,944,780,600, and the highest JNJ revenue forecast at $262,203,104,106,492.

In 2023, JNJ is forecast to generate $268,808,500,509,470 in revenue, with the lowest revenue forecast at $265,884,185,470,335 and the highest revenue forecast at $272,860,778,045,943.

What is JNJ's forecast return on assets (ROA) for 2021-2024?

(NYSE: JNJ) forecast ROA is 17.23%, which is higher than the forecast US Drug Manufacturers - General industry average of 15.85%.

What is JNJ's Price Target?

According to 4 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $189.50, with the highest JNJ stock price forecast at $200.00 and the lowest JNJ stock price forecast at $178.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could stay at $189.50 by Oct 20, 2022. The average Johnson & Johnson stock price prediction forecasts a potential downside of N/A from the current JNJ share price of $163.36.

What is JNJ's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $6.78. On average, analysts forecast that JNJ's EPS will be $9.65 for 2021, with the lowest EPS forecast at $9.60, and the highest EPS forecast at $9.68. On average, analysts forecast that JNJ's EPS will be $10.30 for 2022, with the lowest EPS forecast at $9.58, and the highest EPS forecast at $10.55. In 2023, JNJ's EPS is forecast to hit $11.14 (min: $10.93, max: $11.30).

What is JNJ's forecast return on equity (ROE) for 2021-2024?

(NYSE: JNJ) forecast ROE is 43.94%, which is considered strong.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.